Press Releases

Press Releases

All Press Releases

March 16, 2023
Press Release

Modra Pharmaceuticals Announces U.S. Patent Issuance for ModraDoc006/r

May 27, 2022
Press Release

Modra Pharmaceuticals Presents In-Depth Data Analysis from Lower Dose Cohort in Phase 2b Study of Oral Taxane ModraDoc006/r in mCRPC Patients at 2022 ASCO Annual Meeting

May 23, 2022
Press Release

Modra Pharmaceuticals to Present New Phase 2b Data at the 2022 ASCO General Annual Meeting on ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer

February 17, 2022
Press Release

Modra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer, at 2022 ASCO GU Annual Meeting

April 27, 2021
Press Release

Modra Pharmaceuticals Appoints Two New Supervisory Board Members Adding Significant Experience in Corporate and Clinical Development

February 12, 2021
Press Release

Modra Pharmaceuticals Presents Preliminary Data from Phase IIb Trial of ModraDoc006/r in Metastatic Prostate Cancer at 2021 ASCO GU Annual Meeting

February 11, 2021
Press Release

ModraDoc006/Ritonavir Offers Promising Therapeutic Option for mCRPC

August 14, 2019
Press Release

Modra Pharmaceuticals Announces First Patients Treated in Phase IIb Metastatic Prostate Cancer Trial